Author: Chen, Junsen; Huang, Rui; Nie, Yiwen; Wen, Xinyue; Wu, Ying
Title: Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 Cord-id: 77zb60vn Document date: 2021_1_4
ID: 77zb60vn
Snippet: Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most effective means to combat the pandemic. Here, we introduced the etiological and serological characteristics of COVID-19, discussed the current stage of development of human monoclonal antibodies against
Document: Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most effective means to combat the pandemic. Here, we introduced the etiological and serological characteristics of COVID-19, discussed the current stage of development of human monoclonal antibodies against SARS-CoV-2 and summarized the antigenic epitopes in the S glycoprotein, which may deepen the understanding of the profile of immune recognition and response against SARS-CoV-2 and provide insight for the design of effective vaccines and antibody-based therapies.
Search related documents:
Co phrase search for related documents- ade antibody dependent enhancement and luciferase reporter: 1
- live virus and long process: 1
- live virus and luciferase reporter: 1, 2, 3, 4, 5, 6
- live virus and luciferase reporter virus: 1
- live virus and lung damage: 1, 2, 3, 4, 5, 6
- luciferase reporter and lung damage: 1
Co phrase search for related documents, hyperlinks ordered by date